These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Lymph Node Ratio in HPV-Associated Oropharyngeal Cancer: Identification of a Prognostic Threshold. Bu DD, Ferrandino R, Robinson EM, Liu S, Miles BA, Teng MS, Yao M, Genden EM, Chai RL. Laryngoscope; 2021 Jan; 131(1):E184-E189. PubMed ID: 32348558 [Abstract] [Full Text] [Related]
7. Clinical vs Microscopic Extranodal Extension and Survival in Oropharyngeal Carcinoma in the Human Papillomavirus Era. Gal TJ, O'Brien KJ, Chen Q, Huang B. Otolaryngol Head Neck Surg; 2020 May; 162(5):693-701. PubMed ID: 32151208 [Abstract] [Full Text] [Related]
10. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma. An Y, Park HS, Kelly JR, Stahl JM, Yarbrough WG, Burtness BA, Contessa JN, Decker RH, Koshy M, Husain ZA. Cancer; 2017 Jul 15; 123(14):2762-2772. PubMed ID: 28323338 [Abstract] [Full Text] [Related]
11. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS). Cannon RB, Houlton JJ, Patel S, Raju S, Noble A, Futran ND, Parvathaneni U, Méndez E. Oral Oncol; 2018 Nov 15; 86():296-300. PubMed ID: 30409315 [Abstract] [Full Text] [Related]
12. Outcomes of surgically treated human papillomavirus-related oropharyngeal squamous cell carcinoma with N3 disease. Zenga J, Haughey BH, Jackson RS, Adkins DR, Aranake-Chrisinger J, Bhatt N, Gay HA, Kallogjeri D, Martin EJ, Moore EJ, Paniello RC, Rich JT, Thorstad WL, Nussenbaum B. Laryngoscope; 2017 Sep 15; 127(9):2033-2037. PubMed ID: 28008626 [Abstract] [Full Text] [Related]
15. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer. Haughey BH, Sinha P. Laryngoscope; 2012 Sep 15; 122 Suppl 2():S13-33. PubMed ID: 22926949 [Abstract] [Full Text] [Related]
16. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma. Freitag J, Wald T, Kuhnt T, Gradistanac T, Kolb M, Dietz A, Wiegand S, Wichmann G. Cancer; 2020 Jan 01; 126(9):1856-1872. PubMed ID: 32032442 [Abstract] [Full Text] [Related]
17. The relevance of the lymph node ratio as predictor of prognosis is higher in HPV-negative than in HPV-positive oropharyngeal squamous cell carcinoma. Meyer MF, Meinrath J, Seehawer J, Lechner A, Odenthal M, Quaas A, Semrau R, Huebbers CU, Marnitz S, Büttner R, Beutner D. Clin Otolaryngol; 2018 Feb 01; 43(1):192-198. PubMed ID: 28714274 [Abstract] [Full Text] [Related]
18. Predictors of overall survival in human papillomavirus-associated oropharyngeal cancer using the National Cancer Data Base. Amini A, Jasem J, Jones BL, Robin TP, McDermott JD, Bhatia S, Raben D, Jimeno A, Bowles DW, Karam SD. Oral Oncol; 2016 May 01; 56():1-7. PubMed ID: 27086480 [Abstract] [Full Text] [Related]
20. Lymph node yield: Impact on oncologic outcomes in oral cavity cancer. Khalil C, Khoury M, Higgins K, Enepekides D, Karam I, Husain ZA, Bayley A, Poon I, Truong T, Chan KKW, Smoragiewicz M, Fu R, Eskander A. Head Neck; 2024 Aug 01; 46(8):1965-1974. PubMed ID: 38344842 [Abstract] [Full Text] [Related] Page: [Next] [New Search]